Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Gearbox Biosciences logo — Antibiotic-free recombinant protein production technology in...

Gearbox Biosciences

Antibiotic-free recombinant protein production technology in E. coli

Founded 2021 Estonia Estonia 6 employees Pre Seed Total: $505.00K Biotechnology

General Information

Company Name Gearbox Biosciences
Founded Year 2021
Location Estonia Estonia +1
Employees 6
Industries Biotechnology
Funding Stage Pre Seed
Social

Get notified when Gearbox Biosciences moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Gearbox Biosciences

Gearbox Biosciences is a biotechnology startup based in Estonia, established in 2021. The company's core focus is on antibiotic-free protein production in E. coli, which is in line with the rising demand for sustainable and environmentally friendly biotech solutions. The recent €380.00K Pre Seed Round investment that took place on 13 October 2023 has attracted attention from prominent investors such as Specialist VC, UniTartu Ventures, Johanna Britt Berzin, AS AMALFI, Siim Sikkut, Hugues Flament, Robert Laud, and Ivo Remmelg. Gearbox Biosciences' slogan "Antibiotic-free recombinant protein production technology in E. coli" indicates its commitment to innovative technologies in the field. With its unique approach and strong investor backing, Gearbox Biosciences is poised to make significant strides in the biotechnology industry.

Taxonomy: Recombinant protein production, E. coli, Antibiotic-free technology, Cell growth decoupling, Synthetic biology, Protein engineering, Biotech startups, Protein expression, Estonian biotech, Innovation, Protein purification, Gene expression, Bioprocessing, Startup technology

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round •••••• 8
Investor Investor
•••• •••• 		13 Oct 2023
Grant •••••• - 17 Mar 2023

Gearbox Biosciences Alternatives & Competitors

Gearbox Biosciences vs
Accelagen
Accelagen

Accelagen is a fast growing Gene-to-Protein company. Accelagen’s gene-to-protein platform integrates...

7 employees
Biotechnology, Health Care
Gearbox Biosciences vs
Nuclera
Nuclera United Kingdom

Bring rapid protein access to your benchtop with eProtein Discovery

Series C
116 employees
Biotechnology, Life Sciences
Gearbox Biosciences vs
Biozilla
Biozilla Vietnam

Good Science, Good People

3 employees

FAQ About Gearbox Biosciences

Antibiotic-free recombinant protein production technology in E. coli
Gearbox Biosciences was founded in 2021.
Gearbox Biosciences is headquartered in Estonia.
Gearbox Biosciences operates in the following industries: Biotechnology.
Gearbox Biosciences has approximately 6 employees.
Gearbox Biosciences has completed 2 funding rounds, raising a total of $505.00K. The latest funding stage is Pre Seed.
Top alternatives and competitors to Gearbox Biosciences include Accelagen, Nuclera, Biozilla, BALTYMAS, U-Protein Express BV. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Gearbox Biosciences and Accelagen are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Gearbox Biosciences and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy